Cargando…
PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer (TNBC) lacks biomarkers for targeted therapy. Auger emitters display the best therapeutic effect, if delivered directly into the nucleus proximal to DNA. The nuclear protein Poly (ADP-ribose)-Polymerase 1 (PARP1) is a suitable target against which few inhibi...
Autores principales: | Ambur Sankaranarayanan, Ramya, Florea, Alexandru, Allekotte, Susanne, Vogg, Andreas T. J., Maurer, Jochen, Schäfer, Laura, Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Morgenroth, Agnieszka, Mottaghy, Felix M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474773/ https://www.ncbi.nlm.nih.gov/pubmed/36104637 http://dx.doi.org/10.1186/s13550-022-00932-9 |
Ejemplares similares
-
Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023) -
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2022) -
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023) -
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2020) -
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
por: Morgenroth, Agnieszka, et al.
Publicado: (2019)